Skip to main content
IMS Events Main banner
    22nd International Myeloma Society Annual Meeting
    Oral Abstract

    Abstract Session 4

    Wednesday, September 17, 2025
    16:30 - 17:20 East Coast USA Time
    Location: Room 718

      Co-Chair(s)

    • Francesco Maura, MD

      Assistant Professor
      Memorial Sloan Kettering
      New York City, New York

    • Diana Cirstea, MD

      Medical Oncologist
      Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School
      Boston, Massachusetts

    Presentations:

    • 16:30 - 16:40 East Coast USA Time
      (OA-27) Composition and Functional State of T and NK Cells in Extramedullary Myeloma Tumor Microenvironment

      Abstract Presenter: Anjana Anilkumar Sithara, MS – University of Ostrava

    • 16:40 - 16:50 East Coast USA Time
      (OA-49) Insights from Cytogenetic Subgroup Analyses in the GMMG-CONCEPT trial with Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma

      Abstract Presenter: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany

    • 16:50 - 17:00 East Coast USA Time
      (OA-28) Midnolin Downregulation Promotes Myelomagenesis via Impacting Ubiquitination Independent Pathway of Protein Degradation

      Abstract Presenter: Anna Besschetnova, PhD (she/her/hers) – Dana-Farber Cancer Institute

    • 17:00 - 17:10 East Coast USA Time
      (OA-72) Deciphering Myeloid Cell Dynamics within the Osteolytic Lesion Tumor Microenvironment to Overcome Immunosuppression in Multiple Myeloma

      Abstract Presenter: Joshua Rivera, PhD – Dana-Farber Cancer Institute

    • 17:10 - 17:20 East Coast USA Time
      (OA-73) Longitudinal Multi-Omic Profiling Uncovers Immune Escape and Predictors of Response in Multiple Myeloma

      Abstract Presenter: Denis J. Ohlstrom (he/him/his) – Georgia Institute of Technology